These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 8796141

  • 21. Ghrelin does not mediate the somatotroph and corticotroph responses to the stimulatory effect of glucagon or insulin-induced hypoglycaemia in humans.
    Broglio F, Prodam F, Gottero C, Destefanis S, Me E, Riganti F, Giordano R, Picu A, Balbo M, Van der Lely AJ, Ghigo E, Arvat E.
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):699-704. PubMed ID: 15163333
    [Abstract] [Full Text] [Related]

  • 22. Aspirin increases the human hypothalamic-pituitary-adrenal axis response to naloxone stimulation.
    Hockings GI, Grice JE, Crosbie GV, Walters MM, Jackson AJ, Jackson RV.
    J Clin Endocrinol Metab; 1993 Aug; 77(2):404-8. PubMed ID: 8393884
    [Abstract] [Full Text] [Related]

  • 23. Pioglitazone reduces the adrenal androgen response to corticotropin-releasing factor without changes in ACTH release in hyperinsulinemic women with polycystic ovary syndrome.
    Romualdi D, Giuliani M, Draisci G, Costantini B, Cristello F, Lanzone A, Guido M.
    Fertil Steril; 2007 Jul; 88(1):131-8. PubMed ID: 17336978
    [Abstract] [Full Text] [Related]

  • 24. Cognitive modulation of the endocrine stress response to a pharmacological challenge in normal and panic disorder subjects.
    Abelson JL, Liberzon I, Young EA, Khan S.
    Arch Gen Psychiatry; 2005 Jun; 62(6):668-75. PubMed ID: 15939844
    [Abstract] [Full Text] [Related]

  • 25. The role of corticosterone in human hypothalamic-pituitary-adrenal axis feedback.
    Raubenheimer PJ, Young EA, Andrew R, Seckl JR.
    Clin Endocrinol (Oxf); 2006 Jul; 65(1):22-6. PubMed ID: 16817814
    [Abstract] [Full Text] [Related]

  • 26. CO2 challenge results in hypothalamic-pituitary-adrenal activation in healthy volunteers.
    van Duinen MA, Schruers KR, Maes M, Griez EJ.
    J Psychopharmacol; 2005 May; 19(3):243-7. PubMed ID: 15888509
    [Abstract] [Full Text] [Related]

  • 27. The hypothalamo-pituitary-adrenal axis across the normal menstrual cycle and in polycystic ovary syndrome.
    Stewart PM, Penn R, Holder R, Parton A, Ratcliffe JG, London DR.
    Clin Endocrinol (Oxf); 1993 Apr; 38(4):387-91. PubMed ID: 8391404
    [Abstract] [Full Text] [Related]

  • 28. Enhanced circadian ACTH release in obese premenopausal women: reversal by short-term acipimox treatment.
    Kok P, Kok SW, Buijs MM, Westenberg JJ, Roelfsema F, Frölich M, Stokkel MP, Meinders AE, Pijl H.
    Am J Physiol Endocrinol Metab; 2004 Nov; 287(5):E848-56. PubMed ID: 15280154
    [Abstract] [Full Text] [Related]

  • 29. The influence of combined oral contraceptives containing drospirenone on hypothalamic-pituitary-adrenocortical axis activity and glucocorticoid receptor expression and function in women with polycystic ovary syndrome.
    Macut D, Božić Antić I, Nestorov J, Topalović V, Bjekić Macut J, Panidis D, Kastratović Kotlica B, Papadakis E, Matić G, Vojnović Milutinović D.
    Hormones (Athens); 2015 Nov; 14(1):109-17. PubMed ID: 25402380
    [Abstract] [Full Text] [Related]

  • 30. Response of the pituitary-adrenal axis to hypoglycemic stress in women with the polycystic ovary syndrome.
    Gennarelli G, Holte J, Stridsberg M, Lundqvist U, Massobrio M, Bäckström T, Berne C.
    J Clin Endocrinol Metab; 1999 Jan; 84(1):76-81. PubMed ID: 9920065
    [Abstract] [Full Text] [Related]

  • 31. Evaluation of the pituitary-adrenal axis in hyperandrogenic women with polycystic ovary syndrome.
    Luboshitzky R, Ishai A, Shen-Or Z, Herer P.
    Neuro Endocrinol Lett; 2003 Jan; 24(3-4):249-54. PubMed ID: 14523365
    [Abstract] [Full Text] [Related]

  • 32. Clinical evidence for a neuromodulator action of endothelin in the hypothalamic-pituitary-adrenal axis in man.
    Haak T, Jungmann E, Haak E, Ehrlich S, Usadel KH.
    Exp Clin Endocrinol Diabetes; 1997 Jan; 105(1):46-52. PubMed ID: 9088894
    [Abstract] [Full Text] [Related]

  • 33. Hypothalamic-pituitary-adrenal axis in abdominal obesity: effects of dexfenfluramine.
    Boushaki FZ, Rasio E, Serri O.
    Clin Endocrinol (Oxf); 1997 Apr; 46(4):461-6. PubMed ID: 9196609
    [Abstract] [Full Text] [Related]

  • 34. A comparison of the naloxone test with the insulin stress test in patients following transsphenoidal surgery.
    McAllister AS, McCance DR, Hadden DR, Bell PM, Leslie H, Sheridan B, Atkinson AB.
    Clin Endocrinol (Oxf); 1999 Feb; 50(2):261-5. PubMed ID: 10396371
    [Abstract] [Full Text] [Related]

  • 35. Hypothalamic-pituitary-adrenocortical axis responses to physostigmine: effects of Alzheimer's disease and gender.
    Peskind ER, Raskind MA, Wingerson D, Pascualy M, Thal LJ, Dobie DJ, Wilkinson CW.
    Biol Psychiatry; 1996 Jul 01; 40(1):61-8. PubMed ID: 8780856
    [Abstract] [Full Text] [Related]

  • 36. Altered morning and nighttime pulsatile corticotropin and cortisol release in polycystic ovary syndrome.
    Invitti C, De Martin M, Delitala G, Veldhuis JD, Cavagnini F.
    Metabolism; 1998 Feb 01; 47(2):143-8. PubMed ID: 9472960
    [Abstract] [Full Text] [Related]

  • 37. [Effect of intrahepatic cholestasis of pregnancy on the functions of hypothalamic-pituitary-adrenocortical axis and adrenal cortex in normal neonates].
    Zhu P, Tao FB, Jiang XM, Hao JH, Wang YL, Xu YY.
    Zhongguo Dang Dai Er Ke Za Zhi; 2010 Jan 01; 12(1):5-8. PubMed ID: 20113624
    [Abstract] [Full Text] [Related]

  • 38. Interactions between the stimulated hypothalamic-pituitary-adrenal axis and leptin in humans.
    Nye EJ, Bornstein SR, Grice JE, Tauchnitz R, Hockings GI, Strakosch CR, Jackson RV, Torpy DJ.
    J Neuroendocrinol; 2000 Feb 01; 12(2):141-5. PubMed ID: 10718909
    [Abstract] [Full Text] [Related]

  • 39. Stimulatory effect of naloxone on plasma cortisol in human: Possible direct stimulatory action at the adrenal cortex.
    Coiro V, Volpi R, Stella A, Venturi N, Chiodera P.
    Regul Pept; 2011 Jan 17; 166(1-3):1-2. PubMed ID: 20728478
    [Abstract] [Full Text] [Related]

  • 40. Effect of flumazenil on basal and naloxone-stimulated ACTH and cortisol release in humans.
    Torpy DJ, Jackson RV, Grice JE, Hockings GI, Crosbie GV, Walters MM.
    Clin Exp Pharmacol Physiol; 1994 Feb 17; 21(2):157-61. PubMed ID: 8039271
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.